Ministry of Education
Raghu Prasad Mailavaram
VIDWAN ID: 182891

Prof Raghu Prasad Mailavaram

Male Doctor of Philosophy
Professor
SHRI VILE PARLE KELAVANI MANDALS INSTITUTE OF PHARMACY, DHULE
Maharashtra
Expertise: Medicinal Chemistry
ORCID 0000-0001-6126-5860 Scopus 55240182000 ResearcherID M-1163-2017
View older version My Dashboard
57 Publications
5 Projects
925 Scopus Citations
820 CrossRef
24 Years 1 Month Total Experience
Publications
57 Total
Articles
49
Books
2
Chapters
6
Activity

No publication activity to display.

Scopus Scopus
925 Citations
21 h-index
CrossRef CrossRef
820 Citations
18 h-index
Google Scholar Google Scholar

Loading Scholar statistics...

Professional Recognition

Career Award for Young Teachers
2004
AICTE
Fast Track Fellowship for Young Scientists
2007
DST-SERC

Community & Membership

No Data Found

There is currently nothing to display here.

APTI
Life Member
Jan 2004

Personal Details

Doctor of Philosophy
2003
N/A
Master of Pharmacy
1997
N/A
Bachelor of Pharmacy
1994
N/A
Professor
Aug 2022 – Present
SHRI VILE PARLE KELAVANI MANDALS INSTITUTE OF PHARMACY, DHULE
Professor
Jul 2007 – Jul 2022
Shri Vishnu College Of Pharmacy | Department of Pharmaceutical Chemistry
Associate Professor
Feb 2004 – Jun 2007
PES College of Pharmacy
Senior Research Associate
Jan 2003 – Jan 2004
GVK Biosciences Private Limited, India
Assistant Professor
Aug 2002 – Dec 2002
Krupanidhi College of Pharmacy
Medical and Health Sciences
Medicinal Chemistry

Related Profiles

Co-Authors (26)

Prof Kiran Kalia
Prof Kiran Kalia N/A
Dr Rakesh K. Tekade
Dr Rakesh K. Tekade National Institute of Pharmaceutical Education and Research (NIPER) - Ahmedabad
Dr Narsaiah B
Dr Narsaiah B CSIR-Indian Institute of Chemical Technology
Prof Raghuram Rao Akkinepally
Prof Raghuram Rao Akkinepally National Institute of Pharmaceutical, Educational and Research, Mohali
Dr Pratap Chandra Acharya
Dr Pratap Chandra Acharya Tripura University
Dr Nirupam Das
Dr Nirupam Das Assam University, Silchar
Dr Vinod Tiwari
Dr Vinod Tiwari Indian Institute of Technology (Banaras Hindu University), Varanasi
Dr Jahnavi Bandla
Dr Jahnavi Bandla Vishnu Institute of Pharmaceutical Education and Research
Dr Rina Das
Dr Rina Das Maharishi Markandeshwar
Dr Gaddamanugu Gayatri
Dr Gaddamanugu Gayatri Guru Nanak Institutions Technical Campus
Dr Sandeep Chandrashekharappa
Dr Sandeep Chandrashekharappa N/A
Dr G N Sastry
Dr G N Sastry CSIR-North East Institute of Science and Technology
Dr Sandeep Chandrashekharappa
Dr Sandeep Chandrashekharappa National Institute of Pharmaceutical Education and Research, Raebareli
Dr B P Nandeshwarappa
Dr B P Nandeshwarappa Davangere University, Davangere
Prof Madhavi Kuchana
Prof Madhavi Kuchana Sri Padmavati Mahila Visvavidyalayam
Prof Deepak Chopra
Prof Deepak Chopra Indian Institute of Science Education & Research (IISER), Bhopal
Dr Rahul Maheshwari
Dr Rahul Maheshwari Narsee Monjee Institute of Management Studies, Mumbai
Ms Bhaveshwari Wagh
Ms Bhaveshwari Wagh PARUL UNIVERSITY
Prof Basavaraj Padmashali
Prof Basavaraj Padmashali Rani Channamma University, Belagavi
Dr Rajwinder Kaur
Dr Rajwinder Kaur Chitkara University, Patiala
Dr N V L SIRISHA MULUKURI
Dr N V L SIRISHA MULUKURI NITTE COLLEGE OF PHARMACEUTICAL SCIENCES
Prof RAMAKRISHNA KARIPEDDI
Prof RAMAKRISHNA KARIPEDDI Andhra University, Visakhapatnam
Dr Bendi Anjaneyulu
Dr Bendi Anjaneyulu KALINGA UNIVERSITY, RAIPUR
Dr G B Dharama Rao
Dr G B Dharama Rao Kommuri Pratap Reddy Institute of Technology
Dr G. Narahari Sastry
Dr G. Narahari Sastry Indian Institute of Technology, Hyderabad
Dr Rahul Maheshwari
Dr Rahul Maheshwari N/A

Scholarly Work

Nutritional security and economic empowerment of rural women through food based interventions & mass media approach
Completed
Agency: Department of Science and Technology Role: Principal Investigator Grant: SSD/WS/002/2012
Amount: ₹27.59 Lac
Duration: 2014 – 2016
design and development of novel fused-pyridinones as P2 receptor antagonists
Completed
Agency: Council of Scientific and Industrial Research Role: Principal Investigator Grant: 01(2346)/09/EMR-II
Amount: ₹16 Lac
Duration: 2010 – 2013
synthesis of some novel hetero fused pyrrolopyrimidines as possible adenosine receptor antagonists
Completed
Agency: Department of Science and Technology Role: Principal Investigator Grant: SR/FTP/CS-59/2007
Amount: ₹20 Lac
Duration: 2008 – 2011
synthesis of some novel hetero fused thienopyrimidines as possible adenosine receptor antagonists
Completed
Agency: Council of Scientific and Industrial Research Role: Co-Principal Investigator Grant: 01(2205)/07/EMR-11
Amount: ₹16 Lac
Duration: 2008 – 2011
synthesis of some novel hetero fused pyrazolopyrimidines as possible adenosine receptor antagonists
Completed
Agency: All India Council for Technical Education Role: Principal Investigator Grant: F.No. 1-51/RID/CA(011)/04-05
Amount: ₹10.50 Lac
Duration: 2005 – 2008

Design and synthesis of some novel heterofused pyrrolo abd pyrazolopyrimidines as potent bronchodilators

University Univ. College of Pharmaceutical Sciences, Andhra University
Year 2012
Downloads 0

Synthesis and biological evaluation of some novel chalcones, pyrazolines and 1,5-banzothiazepines

University University College of Pharmaceutical Sciences, Andhra University
Year 2019
Downloads 0

Analytical method development and validation of the selected combination of novel drugs by RP-UPLC

University Univrsity College of Pharmaceutical Sciences, Andhra University
Year 2022
Downloads 0

Benzylidene derivatives of fenobam as anti-inflammatory agents

King Faisal University
- Patent No. : US 11,905,279 B1 Filed : 13-10-2023
Published : 20-02-2024 Granted

Thieno[2,3-d]pyrimidines as Cox-2 inhibitors

King Faisal University
- Patent No. : US 11,932,656B1 Filed : 06-10-2023
Published : 19-03-2024 Granted

3-Cyano 4,5-diphenyl furan-2-carboxamides as antitubercular agents

King Faisal University
- Patent No. : US 11,987,563 B1 Filed : 21-09-2023
Published : 21-05-2024 Granted

1-substituted benzoyl-4- bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents

King Faisal University
- Patent No. : US 11,919,900B1 Filed : 21-08-2023
Published : 05-03-2024 Granted

(E)-2,3,5-Trihydroxy-5-(5-(1-(4-isobutylphenyl)ethyl)-1,3,4-oxadiazol-2-yl)cyclohexyl-(3,4-dihydroxyphenyl)acrylate as a potent anticancer agent.

Shri Vishnu College of Pharmacy
- Patent No. : 202141052261 A Filed : 03-05-2021
Published : 19-05-2023 Published

4- Hydrazino-6-alkyl-1-phenyl-1H-heterofused[3,4-d]pyrimidine as a potent antiasthmatic agent with potent and selective adenosine A3 receptor antagonism.

Shri Vishnu College of Pharmacy
- Patent No. : 342656 Filed : 01-04-2014
Published : 01-05-2016 Granted

Alkyl-7- aryl-7H-heterofused[4,3-e]tetrazolo[1,5-c]pyrimidine as a potent antiasthmatic agent with potent and selective adenosine A3 receptor antagonism.

Shri Vishnu College of Pharmacy
- Patent No. : 318488 Filed : 01-04-2014
Published : 02-05-2016 Granted

7-Aryl-4-hydrazinyl-2,5,6-trialkyl-7H-heterofused[2,3-d]pyrimidine as potent antimycobacterial/antimalarial agent.

Shri Vishnu College of Pharmacy
- Patent No. : 304256 Filed : 20-08-2012
Published : 01-05-2015 Granted

Scholarly Publications

Synthesis and analgesic activity of some novel 2-substituted 1,3,4-thiadiazolo[2,3-b] disubstituted/tetrasubstituted thieno[3,2-e] pyrimidin-5(4H)-ones

Journal Article
Arzneimittelforschung. Year: 2000. Volume: 50 , Issue: 10 , Pages: 904-909 .
Authors: Mailavaram Prasad; Urvishbhai Pathak; Akkinepalli Rao
DOI 10.1055/s-0031-1300315 Scopus Scopus: 13

Recent perspectives in the design of antiasthmatic agents

Review
Year: 2000. Volume: 55 , Issue: 7 , Pages: 475-482 .
Scopus Scopus: 16

A facile route for the synthesis of thienopyrimidines

Open Access
Journal Article
Journal of Chemical Research. Year: 2002. Issue: 1 , Pages: 5-6 .
Authors: M. Raghu Prasad; A. Raghuram Rao; P. Shanthan Rao; K. Subramanian Rajan
DOI 10.3184/030823402103170439 Crossref Crossref: 4 Scopus Scopus: 2

Pharmacology of Acetylcholine and Cholinergic Receptors

Book Chapter
Year: 2020. Pages: 69-105 .
Authors: Sarah Falah Kokaz; Pran Kishore Deb; Sara Nidal Abed; Amal Al-Aboudi; Nirupam Das; Fatimah Amin Younes; Ruba Anwar Salou; Yazan A. Bataineh; Katharigatta N. Venugopala; Raghu Prasad Mailavaram
DOI 10.1007/978-981-15-3556-7_3 Crossref Crossref: 5 Scopus Scopus: 10

Pharmacology of Adenosine Receptors

Open Access
Book Chapter
Year: 2020. Pages: 325-359 .
Authors: Pran Kishore Deb; Sarah Falah Kokaz; Sara Nidal Abed; Balakumar Chandrasekaran; Wafa Hourani; Abdulmuttaleb Yousef Jaber; Raghu Prasad Mailavaram; Puneet Kumar; Katharigatta N. Venugopala
DOI 10.1007/978-981-15-3556-7_10 Crossref Crossref: 1 Scopus Scopus: 1

Recent insight into the biological activities and SAR of quinolone derivatives as multifunctional scaffold

Review
Bioorganic & Medicinal Chemistry. Year: 2022. Volume: 59 .
Authors: Vishal Sharma; Rina Das; Dinesh Kumar Mehta; Sumeet Gupta; Katharigatta N. Venugopala; Raghuprasad Mailavaram; Anroop B. Nair; Ashok K. Shakya; Pran Kishore Deb
DOI 10.1016/j.bmc.2022.116674 Crossref Crossref: 53 Scopus Scopus: 53

Recent approaches in the drug research and development of novel antimalarial drugs with new targets

Open Access
Review
Year: 2023. Volume: 73 , Issue: 1 , Pages: 1-27 .
Authors: Naveen Kumar Reddy Chinnappanna; Gopi Yennam; Chaitanya Budagam Haima Naga Venkata Chaitanya; Shinu Pottathil; Pobitra Borah; Katharigatta N. Venugopala; Pran Kishore Deb; Raghu Prasad Mailavaram
DOI 10.2478/acph-2023-0001 Crossref Crossref: 14 Scopus Scopus: 13

Pks 13 inhibitors—a promising target for future antitubercular agents

Review
Medicinal Chemistry Research. Year: 2023. Volume: 32 , Issue: 8 , Pages: 1574-1588 .
Authors: Naga Tejaswi Uppumavuluri; Sri Ram Krovvidi; Raghu Prasad Mailavaram; Sujit Kumar Mohanty; Pran Kishore Deb; Katharigatta N. Venugopala
DOI 10.1007/s00044-023-03107-w Crossref Crossref: 4 Scopus Scopus: 6
Showing 1 to 8 of 57 publications